Data from Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency
Anirban Das and Uri Tabori and Lauren C. Sambira Nahum and Natalie B. Collins and Rebecca Deyell and Rina Dvir and Cecile Faure-Conter and Timothy E. Hassall and Jane E. Minturn and Melissa Edwards and Elissa Brookes and Vanessa Bianchi and Adrian Levine and Simone C. Stone and Sumedha Sudhaman and Santiago Sanchez Ramirez and Ayse B. Ercan and Lucie Stengs and Jill Chung and Logine Negm and Gad Getz and Yosef E. Maruvka and Birgit Ertl-Wagner and Pamela S. Ohashi and Trevor Pugh and Cynthia Hawkins and Eric Bouffet and Daniel A. Morgenstern
DOI: 10.1158/1078-0432.c.6678040.v2
12/2023

Suppl Figure S1 from Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency
Anirban Das and Uri Tabori and Lauren C. Sambira Nahum and Natalie B. Collins and Rebecca Deyell and Rina Dvir and Cecile Faure-Conter and Timothy E. Hassall and Jane E. Minturn and Melissa Edwards and Elissa Brookes and Vanessa Bianchi and Adrian Levine and Simone C. Stone and Sumedha Sudhaman and Santiago Sanchez Ramirez and Ayse B. Ercan and Lucie Stengs and Jill Chung and Logine Negm and Gad Getz and Yosef E. Maruvka and Birgit Ertl-Wagner and Pamela S. Ohashi and Trevor Pugh and Cynthia Hawkins and Eric Bouffet and Daniel A. Morgenstern
DOI: 10.1158/1078-0432.23284771.v1
06/2023

Trial protocol 1 from Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency
Anirban Das and Uri Tabori and Lauren C. Sambira Nahum and Natalie B. Collins and Rebecca Deyell and Rina Dvir and Cecile Faure-Conter and Timothy E. Hassall and Jane E. Minturn and Melissa Edwards and Elissa Brookes and Vanessa Bianchi and Adrian Levine and Simone C. Stone and Sumedha Sudhaman and Santiago Sanchez Ramirez and Ayse B. Ercan and Lucie Stengs and Jill Chung and Logine Negm and Gad Getz and Yosef E. Maruvka and Birgit Ertl-Wagner and Pamela S. Ohashi and Trevor Pugh and Cynthia Hawkins and Eric Bouffet and Daniel A. Morgenstern
DOI: 10.1158/1078-0432.23284759
06/2023

Supplementary Table S1 from Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency
Anirban Das and Uri Tabori and Lauren C. Sambira Nahum and Natalie B. Collins and Rebecca Deyell and Rina Dvir and Cecile Faure-Conter and Timothy E. Hassall and Jane E. Minturn and Melissa Edwards and Elissa Brookes and Vanessa Bianchi and Adrian Levine and Simone C. Stone and Sumedha Sudhaman and Santiago Sanchez Ramirez and Ayse B. Ercan and Lucie Stengs and Jill Chung and Logine Negm and Gad Getz and Yosef E. Maruvka and Birgit Ertl-Wagner and Pamela S. Ohashi and Trevor Pugh and Cynthia Hawkins and Eric Bouffet and Daniel A. Morgenstern
DOI: 10.1158/1078-0432.23284762.v1
06/2023

Suppl Table S2 from Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency
Anirban Das and Uri Tabori and Lauren C. Sambira Nahum and Natalie B. Collins and Rebecca Deyell and Rina Dvir and Cecile Faure-Conter and Timothy E. Hassall and Jane E. Minturn and Melissa Edwards and Elissa Brookes and Vanessa Bianchi and Adrian Levine and Simone C. Stone and Sumedha Sudhaman and Santiago Sanchez Ramirez and Ayse B. Ercan and Lucie Stengs and Jill Chung and Logine Negm and Gad Getz and Yosef E. Maruvka and Birgit Ertl-Wagner and Pamela S. Ohashi and Trevor Pugh and Cynthia Hawkins and Eric Bouffet and Daniel A. Morgenstern
DOI: 10.1158/1078-0432.23284768.v1
06/2023

Immunohistochemical Study of Histone Protein 3 Modification in Pediatric Osteosarcoma Identifies Reduced H3K27me3 as a Marker of Poor Treatment Response
medRxiv
DOI: 10.1101/2023.09.13.23295510
2023

Prediction of whole body composition utilizing cross-sectional abdominal imaging in pediatrics
European Journal of Clinical Nutrition
DOI: 10.1038/s41430-023-01272-0
2023

Human ASXL1 Deficiency Causes Epigenetic Dysfunction, Combined Immunodeficiency and EBV–Associated Hodgkin Lymphoma
medRxiv
DOI: 10.1101/2023.12.20.23300096
2023

Ensuring access to innovative therapies for children, adolescents, and young adults across Canada: The single patient study experience
Paediatrics and Child Health (Canada)
DOI: 10.1093/pch/pxac122
2023

Brentuximab vedotin after autologous transplantation in pediatric patients with relapsed/refractory Hodgkin lymphoma
Blood Advances
DOI: 10.1182/bloodadvances.2022009323
2023

Performance of the eHealth decision support tool, MIPOGG, for recognising children with Li-Fraumeni, DICER1, Constitutional mismatch repair deficiency and Gorlin syndromes
Journal of Medical Genetics
DOI: 10.1136/jmg-2023-109376
2023

Whole genome transcriptome analysis in a case of a neonatal soft tissue sarcoma with YWHAE:NUTM2B fusion
Pediatric Blood and Cancer
DOI: 10.1002/pbc.30310
2023

Parents’ expectations, preferences, and recall of germline findings in a childhood cancer precision medicine trial
Cancer
DOI: 10.1002/cncr.34917
2023

Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency
Clinical cancer research : an official journal of the American Association for Cancer Research
DOI: 10.1158/1078-0432.CCR-23-0411
2023

Diagnostic and treatment intervals are not associated with survival in rhabdomyosarcoma: A Cancer in Young People in Canada study
Pediatric Blood & Cancer
Sapna Oberoi and Pascal Lambert and Abha A. Gupta and Rebecca J. Deyell and Lillian Sung and Geoffrey D. E. Cuvelier
DOI: 10.1002/pbc.29306
01/2022

Catecholamines in neuroblastoma: Driver of hypertension, or solely a marker of disease?
Cancer Reports
DOI: 10.1002/cnr2.1569
2022

Quality of Life (QoL) of Children and Adolescents Participating in a Precision Medicine Trial for High-Risk Childhood Cancer
Cancers
DOI: 10.3390/cancers14215310
2022

Low-Dose Metronomic Topotecan and Pazopanib (TOPAZ) in Children with Relapsed or Refractory Solid Tumors: A C17 Canadian Phase I Clinical Trial
Cancers
DOI: 10.3390/cancers14122985
2022

Residual meta-iodobenzyl guanidine (MIBG) positivity following therapy for metastatic neuroblastoma: Patient characteristics, imaging, and outcome
Pediatric Blood & Cancer
Nida Usmani and Rebecca J. Deyell and Carol Portwine and Margarida Simao Rafael and Paul C. Moorehead and Amer Shammas and Reza Vali and Mateo Farfan and Thuvaraha Vanniyasingam and Daniel A. Morgenstern and Meredith S. Irwin
DOI: 10.1002/pbc.29289
12/2021

Crizotinib response in a neuroblastoma patient with a constitutional mosaic anaplastic lymphoma kinase I1170N-activating mutation
Pediatric Blood & Cancer
Melissa Harvey and Meredith S. Irwin and Linlea Armstrong and Kim Seath and Sean Young and Sharon Gershony and Rebecca J. Deyell
DOI: 10.1002/pbc.28916
06/2021

Canadian consensus on TRK-inhibitor therapy for NTRK fusion-positive sarcoma
International Journal of Cancer
Simmons, C. and Deyell, R.J. and MacNeill, A.J. and Vera-Badillo, F.E. and Smrke, A. and Abdul Razak, A.R. and Banerji, S. and McLeod, D. and Noujaim, J.
DOI: 10.1002/ijc.33723
2021

Clinical response to nivolumab in an INI1-deficient pediatric chordoma correlates with immunogenic recognition of brachyury
npj Precision Oncology
Williamson, L.M. and Rive, C.M. and Di Francesco, D. and Titmuss, E. and Chun, H.-J.E. and Brown, S.D. and Milne, K. and Pleasance, E. and Lee, A.F. and Yip, S. and Rosenbaum, D.G. and Hasselblatt, M. and Johann, P.D. and Kool, M. and Harvey, M. and Dix, D. and Renouf, D.J. and Holt, R.A. and Nelson, B.H. and Hirst, M. and Jones, S.J.M. and Laskin, J. and Rassekh, S.R. and Deyell, R.J. and Marra, M.A.
DOI: 10.1038/s41698-021-00238-4
2021

Life-Threatening Intratumoral Hemorrhage in an Infant with Hepatoblastoma Successfully Treated with Hepatic Arterial Embolization
Journal of Vascular and Interventional Radiology
Ronsley, R. and Cardarelli-Leite, L. and Burrill, J. and Deyell, R.J. and Heran, M.K.S.
DOI: 10.1016/j.jvir.2021.04.007
2021

Precocious puberty: A red flag for malignancy in childhood
British Columbia Medical Journal
D?alessandro, P.R. and Hamilton, J. and Khatchadourian, K. and Lunaczek-Motyka, E. and Schultz, K.R. and Metzger, D. and Deyell, R.J.
2021

Canadian consensus for biomarker testing and treatment of TRK fusion cancer in pediatric patients
Current Oncology
Perreault, S. and Chami, R. and Deyell, R.J. and Demellawy, D.E. and Ellezam, B. and Jabado, N. and Morgenstern, D.A. and Narendran, A. and Sorensen, P.H.B. and Wasserman, J.D. and Yip, S.
DOI: 10.3390/curroncol28010038
2021

Performance of the McGill Interactive Pediatric OncoGenetic Guidelines for Identifying Cancer Predisposition Syndromes
JAMA Oncology
Goudie, C. and Witkowski, L. and Cullinan, N. and Reichman, L. and Schiller, I. and Tachdjian, M. and Armstrong, L. and Blood, K.A. and Brossard, J. and Brunga, L. and Cacciotti, C. and Caswell, K. and Cellot, S. and Clark, M.E. and Clinton, C. and Coltin, H. and Felton, K. and Fernandez, C.V. and Fleming, A.J. and Fuentes-Bolanos, N. and Gibson, P. and Grant, R. and Hammad, R. and Harrison, L.W. and Irwin, M.S. and Johnston, D.L. and Kane, S. and Lafay-Cousin, L. and Lara-Corrales, I. and Larouche, V. and Mathews, N. and Meyn, M.S. and Michaeli, O. and Perrier, R. and Pike, M. and Punnett, A. and Ramaswamy, V. and Say, J. and Somers, G. and Tabori, U. and Thibodeau, M.L. and Toupin, A.-K. and Tucker, K.M. and Van Engelen, K. and Vairy, S. and Waespe, N. and Warby, M. and Wasserman, J.D. and Whitlock, J.A. and Sinnett, D. and Jabado, N. and Nathan, P.C. and Shlien, A. and Kamihara, J. and Deyell, R.J. and Ziegler, D.S. and Nichols, K.E. and Dendukuri, N. and Malkin, D. and Villani, A. and Foulkes, W.D.
DOI: 10.1001/jamaoncol.2021.4536
2021

NTRK2 Fusion driven pediatric glioblastoma: Identification of oncogenic Drivers via integrative Genome and transcriptome profiling
Clinical Case Reports
Britton, H.M. and Levine, A.B. and Shen, Y. and Mungall, K. and Serrano, J. and Snuderl, M. and Pleasance, E. and Jones, S.J.M. and Laskin, J. and Marra, M.A. and Rassekh, S.R. and Deyell, R. and Yip, S. and Cheng, S. and Dunham, C.
DOI: 10.1002/ccr3.3804
2021

Parent Perspectives on Information-seeking, Trustworthiness, and Decision-making in High-risk Neuroblastoma.
Journal of pediatric hematology/oncology
Brown K and Benjaminy S and Illes J and Deyell RJ
DOI: 10.1097/mph.0000000000002022
PubMed: 33273412
12/2020

Evaluating the quantity, quality and size distribution of cell-free DNA by multiplex droplet digital PCR.
Scientific reports
Alcaide M and Cheung M and Hillman J and Rassekh SR and Deyell RJ and Batist G and Karsan A and Wyatt AW and Johnson N and Scott DW and Morin RD
DOI: 10.1038/s41598-020-69432-x
PubMed: 32724107
07/2020

Establishing a Framework for the Clinical Translation of Germline Findings in Precision Oncology.
JNCI cancer spectrum
Dixon K and Young S and Shen Y and Thibodeau ML and Fok A and Pleasance E and Zhao E and Jones M and Aubert G and Armstrong L and Virani A and Regier D and Gelmon K and Renouf D and Chia S and Schrader KA
DOI: 10.1093/jncics/pkaa045
PubMed: 33134827
05/2020

Ifosfamide, gemcitabine, and vinorelbine is an effective salvage regimen with excellent stem cell mobilization in relapsed or refractory pediatric Hodgkin lymphoma
Pediatric Blood and Cancer
Marr, K. and Ronsley, R. and Nadel, H. and Douglas, K. and Gershony, S. and Strahlendorf, C. and Davis, J.H. and Deyell, R.J.
DOI: 10.1002/pbc.28167
2020

The Utility of PET/CT in Guiding Radiotherapy Reduction for Children with Hodgkin Lymphoma Treated with ABVD
Journal of Pediatric Hematology/Oncology
Ingley, K.M. and Nadel, H.R. and Potts, J.E. and Wilson, D.C. and Eftekhari, A. and Deyell, R.J.
DOI: 10.1097/MPH.0000000000001534
2020

ALK-Positive Lung Adenocarcinoma Arising in an Adolescent Treated for Relapsed Neuroblastoma
Journal of Thoracic Oncology
Alwelaie, Y. and Deyell, R.J. and Nadel, H.R. and Tucker, T. and Laskin, J. and Rassekh, S.R. and Zhou, C. and English, J.C. and Lee, A.F.
DOI: 10.1016/j.jtho.2019.02.010
2019

Therapeutic implication of genomic landscape of adult metastatic sarcoma
JCO Precision Oncology
Feng, X. and Pleasance, E. and Zhao, E.Y. and Ng, T. and Grewal, J.K. and Mohammad, N. and Taylor, S.K. and Simmons, C. and Srikanthan, A. and Rod Rassekh, S. and Deyell, R. and Rauw, J. and Knowling, M. and Khoo, K. and Lee, U. and Noonan, K. and Hart, J. and Petter Tonseth, R. and Shen, Y. and Titmuss, E. and Jones, M. and Bonakdar, M. and Reisle, C. and Taylor, G.A. and Chan, S. and Mungall, K. and Chuah, E. and Zhao, Y. and Mungall, A. and Moore, R. and Lim, H. and Renouf, D.J. and Gelmon, K. and Yip, S. and Jones, S.J.M. and Marra, M. and Laskin, J.
DOI: 10.1200/PO.18.00325
2019

Comparative Tumor RNA Sequencing Analysis for Difficult-to-Treat Pediatric and Young Adult Patients With Cancer
JAMA network open
Vaske, O.M. and Bjork, I. and Salama, S.R. and Beale, H. and Tayi Shah, A. and Sanders, L. and Pfeil, J. and Lam, D.L. and Learned, K. and Durbin, A. and Kephart, E.T. and Currie, R. and Newton, Y. and Swatloski, T. and McColl, D. and Vivian, J. and Zhu, J. and Lee, A.G. and Leung, S.G. and Spillinger, A. and Liu, H.-Y. and Liang, W.S. and Byron, S.A. and Berens, M.E. and Resnick, A.C. and Lacayo, N. and Spunt, S.L. and Rangaswami, A. and Huynh, V. and Torno, L. and Plant, A. and Kirov, I. and Zabokrtsky, K.B. and Rassekh, S.R. and Deyell, R.J. and Laskin, J. and Marra, M.A. and Sender, L.S. and Mueller, S. and Sweet-Cordero, E.A. and Goldstein, T.C. and Haussler, D.
DOI: 10.1001/jamanetworkopen.2019.13968
2019

Phase I dose-finding study for melatonin in pediatric oncology patients with relapsed solid tumors
Pediatric Blood and Cancer
Johnston, D.L. and Zupanec, S. and Nicksy, D. and Morgenstern, D. and Narendran, A. and Deyell, R.J. and Samson, Y. and Wu, B. and Baruchel, S.
DOI: 10.1002/pbc.27676
2019

Phase I study of vinblastine and temsirolimus in pediatric patients with recurrent or refractory solid tumors: Canadian Cancer Trials Group Study IND.218
Pediatric Blood and Cancer
Deyell, R.J. and Wu, B. and Rassekh, S.R. and Tu, D. and Samson, Y. and Fleming, A. and Bouffet, E. and Sun, X. and Powers, J. and Seymour, L. and Baruchel, S. and Morgenstern, D.A.
DOI: 10.1002/pbc.27540
2019

Pediatric oncology and stem cell transplant patients with healthcare-associated Clostridium difficile infection were already colonized on admission
Pediatric Blood and Cancer
Al-Rawahi, G.N. and Al-Najjar, A. and McDonald, R. and Deyell, R.J. and Golding, G.R. and Brant, R. and Tilley, P. and Thomas, E. and Rassekh, S.R. and O'Gorman, A. and Wong, P. and Turnham, L. and Dobson, S.
DOI: 10.1002/pbc.27604
2019

Tumor Variant Identification That Accounts for the Unique Molecular Landscape of Pediatric Malignancies.
JNCI cancer spectrum
Lorentzian A and Biegel JA and Ostrow DG and Rolf N and Liu CC and Rassekh SR and Deyell RJ and Triche T and Schultz KR and Rozmus J and Reid GSD and Lim CJ and Lange PF and Maxwell CA
DOI: 10.1093/jncics/pky079
PubMed: 30976750
10/2018

Comparative RNA-Sequencing Analysis Benefits a Pediatric Patient With Relapsed Cancer.
JCO precision oncology
Newton Y and Rassekh SR and Deyell RJ and Shen Y and Jones MR and Dunham C and Yip S and Leelakumari S and Zhu J and McColl D and Swatloski T and Salama SR and Ng T and Hendson G and Lee AF and Morozova O
04/2018

Comparative RNA-sequencing analysis benefits a pediatric patient with relapsed cancer
JCO Precision Oncology
Newton, Y. and Rassekh, S.R. and Deyell, R.J. and Shen, Y. and Jones, M.R. and Dunham, C. and Yip, S. and Leelakumari, S. and Zhu, J. and McColl, D. and Swatloski, T. and Salama, S.R. and Ng, T. and Hendson, G. and Lee, A.F. and Ma, Y. and Moore, R. and Mungall, A.J. and Haussler, D. and Stuart, J.M. and Jantzen, C. and Laskin, J. and Jones, S.J.M. and Marra, M.A. and Morozova, O.
DOI: 10.1200/PO.17.00198
2018

Developing liposomal nanomedicines for treatment of patients with neuroblastoma
Lipid Nanocarriers for Drug Targeting
DOI: 10.1016/B978-0-12-813687-4.00009-8
2018

Application of genomics to identify therapeutic targets in recurrent pediatric papillary thyroid carcinoma
Cold Spring Harbor Molecular Case Studies
Ronsley, R. and Rod Rassekh, S. and Shen, Y. and Lee, A.F. and Jantzen, C. and Halparin, J. and Albert, C. and Hawkins, D.S. and Amed, S. and Rothstein, R. and Mungall, A.J. and Dix, D. and Blair, G. and Nadel, H. and Jones, S.J.M. and Laskin, J. and Marra, M.A. and Deyell, R.J.
DOI: 10.1101/mcs.a002568
2018

ABVD chemotherapy with reduced radiation therapy rates in children, adolescents and young adults with all stages of Hodgkin lymphoma.
Annals of Oncology
DOI: 10.1093/annonc/mdx005
PubMed: 28327925
04/2017

Nivolumab in the Treatment of Refractory Pediatric Hodgkin Lymphoma
Journal of Pediatric Hematology/Oncology
Foran, A.E. and Nadel, H.R. and Lee, A.F. and Savage, K.J. and Deyell, R.J.
DOI: 10.1097/MPH.0000000000000703
2017

Optimization of liposomal topotecan for use in treating neuroblastoma
Cancer Medicine
Chernov, L. and Deyell, R.J. and Anantha, M. and Dos Santos, N. and Gilabert-Oriol, R. and Bally, M.B.
DOI: 10.1002/cam4.1083
2017

Targeted error-suppressed quantification of circulating tumor DNA using semi-degenerate barcoded adapters and biotinylated baits
Scientific Reports
Alcaide, M. and Yu, S. and Davidson, J. and Albuquerque, M. and Bushell, K. and Fornika, D. and Arthur, S. and Grande, B.M. and McNamara, S. and Tertre, M.C.D. and Batist, G. and Huntsman, D.G. and Cavallone, L. and Aguilar, A. and Basik, M. and Johnson, N.A. and Deyell, R.J. and Rassekh, S.R. and Morin, R.D.
DOI: 10.1038/s41598-017-10269-2
2017

ETV6-NTRK3 is Expressed in a Subset of ALK-Negative Inflammatory Myofibroblastic Tumors
American Journal of Surgical Pathology
Alassiri, A.H. and Ali, R.H. and Shen, Y. and Lum, A. and Strahlendorf, C. and Deyell, R. and Rassekh, R. and Sorensen, P.H. and Laskin, J. and Marra, M. and Yip, S. and Lee, C.-H. and Ng, T.L.
DOI: 10.1097/PAS.0000000000000677
2016

Lessons learned from the application of whole-genome analysis to the treatment of patients with advanced cancers.
Cold Spring Harbor Molecular Case Studies
DOI: 10.1101/mcs.a000570
PubMed: 27148575
10/2015

Molecular oncology of neuroblastoma
Molecular Oncology: Causes of Cancer and Targets for Treatment
DOI: 10.1017/CBO9781139046947.060
2015

Dexmedetomidine and hydromorphone: A novel pain management strategy for the oncology ward setting during anti-GD2 immunotherapy for high-risk neuroblastoma in children
Pediatric Blood and Cancer
Görges, M. and West, N. and Deyell, R. and Winton, P. and Cheung, W. and Lauder, G.
DOI: 10.1002/pbc.25197
2015

Antidepressant use among survivors of childhood, adolescent, and young adult cancer: Letter to the editor response
Pediatric Blood and Cancer
Deyell, R.J. and Lorenzi, M. and Spinelli, J.J. and Mcbride, M.L.
DOI: 10.1002/pbc.24885
2014

Neuroblastoma in older children, adolescents and young adults: A report from the International Neuroblastoma Risk Group project
Pediatric Blood and Cancer
Mossé, Y.P. and Deyell, R.J. and Berthold, F. and Nagakawara, A. and Ambros, P.F. and Monclair, T. and Cohn, S.L. and Pearson, A.D. and London, W.B. and Matthay, K.K.
DOI: 10.1002/pbc.24777
2014

Paroxysmal nocturnal haemoglobinuria phenotype cells and leucocyte subset telomere length in childhood acquired aplastic anaemia
British Journal of Haematology
Tutelman, P.R. and Aubert, G. and Milner, R.A. and Dalal, B.I. and Schultz, K.R. and Deyell, R.J.
DOI: 10.1111/bjh.12656
2014

Antidepressant use among survivors of childhood, adolescent and young adult cancer: A report of the childhood, adolescent and young adult cancer survivor (CAYACS) research program
Pediatric Blood and Cancer
Deyell, R.J. and Lorenzi, M. and Ma, S. and Rassekh, S.R. and Collet, J.-P. and Spinelli, J.J. and Mcbride, M.L.
DOI: 10.1002/pbc.24446
2013

Immunosuppressive therapy without hematopoietic growth factor exposure in pediatric acquired aplastic anemia
Pediatric Hematology and Oncology
Deyell, R.J. and Shereck, E.B. and Milner, R.A. and Schultz, K.R.
DOI: 10.3109/08880018.2011.568043
2011

Advances in the understanding of constitutional and somatic genomic alterations in neuroblastoma
Cancer Genetics
Deyell, R.J. and Attiyeh, E.F.
DOI: 10.1016/j.cancergen.2011.03.001
2011

Costs and consequences of immunosuppressive therapy in children with aplastic anemia
Haematologica
Shereck, E.B. and Deyell, R.J. and Kurre, P.
DOI: 10.3324/haematol.2011.044917
2011

Low oxygen saturation by pulse oximetry may be associated with a low oxygen affinity hemoglobin variant, hemoglobin Titusville
Journal of Pediatric Hematology/Oncology
Deyell, R. and Jackson, S. and Spier, S. and Le, D. and Poon, M.-C.
DOI: 10.1097/01.mph.0000200685.33291.0a
2006